Nagi Ravleen, Sahu Shashikant, Rakesh N
Department of Oral Medicine and Radiology, New Horizon Dental College and Research Institute, Bilaspur, Chhattisgarh, India.
Department of Plastic Surgery, Burn and Trauma Centre, Bilaspur, Chhattisgarh, India.
J Oral Maxillofac Pathol. 2016 Sep-Dec;20(3):497-504. doi: 10.4103/0973-029X.190954.
Ameloblastoma is the second most common benign epithelial odontogenic tumor and though it is of a benign nature, it is locally invasive, has a high recurrence rate and could potentially become malignant. Many theories have been proposed to explain the pathogenesis of ameloblastoma. Proper understanding of the pathogenic mechanism involved in ameloblastoma and its proliferation aids in constituting proper treatment of choice at an early stage, preventing morbidity associated with extensive therapy. An attempt has been made to discuss the current concepts related to molecular and genetic changes that occur in ameloblastoma as these could affect treatment plan and prognosis.
成釉细胞瘤是第二常见的良性上皮性牙源性肿瘤,尽管它本质上是良性的,但具有局部侵袭性,复发率高,并且有可能恶变。人们提出了许多理论来解释成釉细胞瘤的发病机制。正确理解成釉细胞瘤及其增殖所涉及的致病机制有助于在早期制定合适的治疗方案,预防与广泛治疗相关的发病率。本文试图讨论与成釉细胞瘤中发生的分子和基因变化相关的当前概念,因为这些变化可能会影响治疗计划和预后。